Related Experiment Video

Updated: Jul 12, 2026

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
08:26

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity

Published on: December 14, 2016

Modalities for the removal of beta 2-microglobulin from blood

G A Ameer1

  • 1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

Seminars in Dialysis
|March 27, 2001
PubMed

Insights

Dialysis-related amyloidosis (DRA) stems from beta(2)-microglobulin (beta(2)M) buildup in kidney failure patients. This review explores methods to clear beta(2)M, including immunoadsorption, for potential DRA treatment.

Area of Science:

  • Nephrology
  • Biochemistry
  • Medical Technology

Background:

  • Dialysis-related amyloidosis (DRA) is a serious complication in patients with kidney failure.
  • Long-term accumulation of beta(2)-microglobulin (beta(2)M) is the primary cause of DRA.
  • Current methods for beta(2)M removal are limited.

Purpose of the Study:

  • To review existing and conceptual methods for beta(2)M clearance from blood.
  • To classify beta(2)M removal approaches by their clearance mechanisms.
  • To discuss the potential of immunoadsorption for treating and understanding DRA.

Main Methods:

  • Literature review of beta(2)M removal techniques.
  • Classification of methods based on clearance mechanisms.
  • Exploration of immunoadsorption as a specific macromolecule removal strategy.

Main Results:

  • Several modalities and concepts for beta(2)M removal exist.
  • Approaches vary in their mechanisms of beta(2)M clearance.
  • Immunoadsorption presents a promising biologically specific approach.

Conclusions:

  • Effective removal of beta(2)M is crucial for managing DRA.
  • Immunoadsorption offers a targeted strategy for beta(2)M reduction.
  • Further research into immunoadsorption could advance DRA treatment.

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells from Buffy Coats via High Throughput Immunomagnetic Bead Separation06:23

Isolating Human Peripheral Blood Mononuclear Cells from Buffy Coats via High Throughput Immunomagnetic Bead Separation

Published on: July 19, 2024

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils08:14

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Published on: November 11, 2025

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...